Your browser doesn't support javascript.
loading
The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastoma.
Neirinckx, Virginie; Hau, Ann-Christin; Schuster, Anne; Fritah, Sabrina; Tiemann, Katja; Klein, Eliane; Nazarov, Petr V; Matagne, André; Szpakowska, Martyna; Meyrath, Max; Chevigné, Andy; Schmidt, Mirko H H; Niclou, Simone P.
Afiliação
  • Neirinckx V; NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg.
  • Hau AC; NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg.
  • Schuster A; NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg.
  • Fritah S; NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg.
  • Tiemann K; NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg.
  • Klein E; NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg.
  • Nazarov PV; Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, Luxembourg.
  • Matagne A; Center for Protein Engineering, University of Liège, Liège, Belgium.
  • Szpakowska M; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg, Germany.
  • Meyrath M; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg, Germany.
  • Chevigné A; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg, Germany.
  • Schmidt MHH; Molecular Signal Transduction Laboratories, Institute for Microscopic Anatomy and Neurobiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Niclou SP; German Cancer Consortium (DKTK), Heidelberg, Germany.
Neurooncol Adv ; 1(1): vdz024, 2019.
Article em En | MEDLINE | ID: mdl-32642659
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Luxemburgo
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Luxemburgo